Novik Y - Search Results

1

Idarubicin and standard-dose cytosine arabinoside in adults with recurrent and refractory acute lymphocytic leukemia.

Karbasian-Esfahani M, Wiernik PH, Novik Y, Paietta E, Dutcher JP. Karbasian-Esfahani M, et al. Among authors: novik y. Cancer. 2004 Sep 15;101(6):1414-9. doi: 10.1002/cncr.20494. Cancer. 2004. PMID: 15368329 Free article. Clinical Trial.

2

Therapeutic effect of cyclosporine A in thrombocytopenia after myeloablative chemotherapy in acute myeloid leukaemia.

Novik Y, Oleksowicz L, Wiernik PH. Novik Y, et al. Med Oncol. 1997 Mar;14(1):43-6. doi: 10.1007/BF02990945. Med Oncol. 1997. PMID: 9232611

3

Familial erythroleukemia: a distinct clinical and genetic type of familial leukemias.

Novik Y, Marino P, Makower DF, Wiernik PH. Novik Y, et al. Leuk Lymphoma. 1998 Jul;30(3-4):395-401. doi: 10.3109/10428199809057551. Leuk Lymphoma. 1998. PMID: 9713970 Review.

4

Successful treatment of a patient on adrenal steroid replacement therapy with high-dose bolus interleukin-2 for metastatic renal cell carcinoma.

Deshpande H, Dutcher JP, Novik Y, Oleksowicz L. Deshpande H, et al. Among authors: novik y. Cancer J Sci Am. 1999 Jan-Feb;5(1):52-3. Cancer J Sci Am. 1999. PMID: 10188062 No abstract available.

5

Therapeutic efficacy of theophylline in chronic lymphocytic leukemia.

Makower D, Malik U, Novik Y, Wiernik PH. Makower D, et al. Among authors: novik y. Med Oncol. 1999 Apr;16(1):69-71. doi: 10.1007/BF02787362. Med Oncol. 1999. PMID: 10382946

6

Phase II protocol for the evaluation of new treatments in patients with advanced gastric carcinoma: results of ECOG 5282.

Novik Y, Ryan LM, Haller DG, Asbury R, Dutcher JP, Schutt A. Novik Y, et al. Med Oncol. 1999 Dec;16(4):261-6. doi: 10.1007/BF02785872. Med Oncol. 1999. PMID: 10618689 Clinical Trial.

7

20th-century advances in drug therapy in oncology--Part I.

Dutcher JP, Novik Y, O'Boyle K, Marcoullis G, Secco C, Wiernik PH. Dutcher JP, et al. Among authors: novik y. J Clin Pharmacol. 2000 Sep;40(9):1007-24. doi: 10.1177/00912700022009620. J Clin Pharmacol. 2000. PMID: 10975071 No abstract available.

8

20th-century advances in drug therapy in oncology--Part. II.

Dutcher JP, Novik Y, O'Boyle K, Marcoullis G, Secco C, Wiernik PH. Dutcher JP, et al. Among authors: novik y. J Clin Pharmacol. 2000 Oct;40(10):1079-92. J Clin Pharmacol. 2000. PMID: 11028247 Review.

9

Phase II study of weekly docetaxel alone or in combination with trastuzumab in patients with metastatic breast cancer.

Raff JP, Rajdev L, Malik U, Novik Y, Manalo JM, Negassa A, Hopkins U, Sarta C, Sparano JA. Raff JP, et al. Among authors: novik y. Clin Breast Cancer. 2004 Feb;4(6):420-7. doi: 10.3816/cbc.2004.n.005. Clin Breast Cancer. 2004. PMID: 15023243 Clinical Trial.

10

A phase 2 study of moderate dose interleukin-2 and granulocyte-macrophage colony-stimulating factor in patients with metastatic or unresectable renal cell carcinoma.

Koulova L, Novik Y, Caliendo G, Wiernik P, Dutcher J. Koulova L, et al. Among authors: novik y. J Immunother. 2005 Nov-Dec;28(6):576-81. doi: 10.1097/01.cji.0000177998.57713.c9. J Immunother. 2005. PMID: 16224275 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters